Delivery Order SPE2DB22D3501-SPE2DB24FWN37

Award Date 8/6/24
Potential Completion Date 8/7/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The order is for 4,561,076,878 units of the prescription drug Ondansetron ODT 4 mg Tablet, at a ceiling value of $1,041.90. The contract is a firm fixed-price delivery order with a completion date of May 31, 2023. The contract award was not designated with a set-aside....
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. It is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999. The contract covers the supply of 4,566,719,877 units of the generic drug Ondansetron ODT 4 mg tablets in 30-count packages. This is a firm fixed-price contract with a ceiling value of $2,677.43 and a completion date...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,857,263 units of the pharmaceutical product Ondansetron ODT 4 mg tablets. The contract has a ceiling value of $8,222.77 and a completion date of April 10, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,116,842 units of the drug Ondansetron ODT 4 mg tablets. The award has a ceiling value of $5,097.98 and an ultimate completion date of October 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This is a $8,769.42 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of 4,564,233,461 units of the pharmaceutical product Ondansetron ODT 4 mg tablets. This delivery order was awarded under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential total value of $999,999,999.00 and a performance...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,164,197 units of the medication Ondansetron ODT 8 mg Tablet. The contract has a ceiling value of $3,567.70 and a performance period through May 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is for the supply of 4560732432 - Ondansetron ODT 4 mg tablets in 30-count packages, with a ceiling value of $3,198.00 and a completion date of April 27, 2023. This delivery order is part of a broader IDC that provides a comprehensive range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,602.89, is for the delivery of 4,561,059,478 units of Ondansetron ODT 4 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,957,266 units of the medication Ondansetron ODT 4 mg tablet. The order has a ceiling value of $5,173.92 and an ultimate completion date of April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,114,688 units of the prescription medication Ondansetron ODT 4 mg tablets. The contract has a ceiling value of $13,585.32 and a performance period extending through May 5, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with DLA Troop Support Medical,...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWN37
    Delivery Order

This contract award to AmerisourceBergen Drug Corp, Corporate Office Division, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999 through December 2025. The award is for the supply of 4,565,366,355 units of the pharmaceutical product Ondansetron ODT 4 mg Tablets, with a ceiling value of $1,081.46. The contract is a firm fixed price arrangement with an ultimate completion date of August 7, 2024. This order supports the healthcare needs of military treatment facilities and other federal beneficiaries. There is no set-aside designation for this contract.

Generated 11/5/24, 9:19 AM